1235 related articles for article (PubMed ID: 33206392)
1. Intravitreal steroids for macular edema in diabetes.
Rittiphairoj T; Mir TA; Li T; Virgili G
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005656. PubMed ID: 33206392
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal steroids for macular edema in diabetes.
Grover D; Li TJ; Chong CC
Cochrane Database Syst Rev; 2008 Jan; (1):CD005656. PubMed ID: 18254088
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
5. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Curran K; Lucenteforte E; Peto T; Parravano M
Cochrane Database Syst Rev; 2023 Jun; 2023(6):CD007419. PubMed ID: 38275741
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroid implants for chronic non-infectious uveitis.
Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD010469. PubMed ID: 36645716
[TBL] [Abstract][Full Text] [Related]
9. Macular grid laser photocoagulation for branch retinal vein occlusion.
Lam FC; Chia SN; Lee RM
Cochrane Database Syst Rev; 2015 May; 2015(5):CD008732. PubMed ID: 25961835
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid implants for chronic non-infectious uveitis.
Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD010469. PubMed ID: 37642198
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
Gewaily D; Muthuswamy K; Greenberg PB
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007324. PubMed ID: 26352007
[TBL] [Abstract][Full Text] [Related]
13. Monotherapy laser photocoagulation for diabetic macular oedema.
Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
[TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
Zhu Y; Zhang T; Xu G; Peng L
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Evans JR
Cochrane Database Syst Rev; 2014 Oct; (10):CD007419. PubMed ID: 25342124
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
Virgili G; Parravano M; Menchini F; Brunetti M
Cochrane Database Syst Rev; 2012 Dec; 12():CD007419. PubMed ID: 23235642
[TBL] [Abstract][Full Text] [Related]
17. Aqueous shunts for glaucoma.
Tseng VL; Coleman AL; Chang MY; Caprioli J
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004918. PubMed ID: 28750481
[TBL] [Abstract][Full Text] [Related]
18. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.
Li E; Donati S; Lindsley KB; Krzystolik MG; Virgili G
Cochrane Database Syst Rev; 2020 May; 5(5):CD012208. PubMed ID: 32374423
[TBL] [Abstract][Full Text] [Related]
19. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.
Martinez-Zapata MJ; Martí-Carvajal AJ; Solà I; Pijoán JI; Buil-Calvo JA; Cordero JA; Evans JR
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008721. PubMed ID: 25418485
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion.
Braithwaite T; Nanji AA; Lindsley K; Greenberg PB
Cochrane Database Syst Rev; 2014 May; 2014(5):CD007325. PubMed ID: 24788977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
